Contrasting Sunwin Stevia International (OTCMKTS:SUWN) and Mirati Therapeutics (OTCMKTS:MRTX)

Mirati Therapeutics (NASDAQ:MRTX) and Sunwin Stevia International (OTCMKTS:SUWN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk.

Earnings & Valuation

This table compares Mirati Therapeutics and Sunwin Stevia International’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Mirati Therapeutics $12.93 million 294.73 -$98.42 million ($3.19) -33.14
Sunwin Stevia International $22.04 million 0.72 -$4.71 million N/A N/A

Sunwin Stevia International has higher revenue and earnings than Mirati Therapeutics.

Volatility and Risk

Mirati Therapeutics has a beta of 2.02, meaning that its stock price is 102% more volatile than the S&P 500. Comparatively, Sunwin Stevia International has a beta of 2.7, meaning that its stock price is 170% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mirati Therapeutics and Sunwin Stevia International, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mirati Therapeutics 0 4 10 0 2.71
Sunwin Stevia International 0 0 0 0 N/A

Mirati Therapeutics currently has a consensus target price of $99.46, indicating a potential downside of 5.91%. Given Mirati Therapeutics’ higher possible upside, equities analysts clearly believe Mirati Therapeutics is more favorable than Sunwin Stevia International.


This table compares Mirati Therapeutics and Sunwin Stevia International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mirati Therapeutics N/A -52.11% -47.44%
Sunwin Stevia International -17.16% -61.78% -12.78%


Mirati Therapeutics beats Sunwin Stevia International on 5 of the 9 factors compared between the two stocks.

About Mirati Therapeutics

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company is involved in developing sitravatinib, a spectrum-selective kinase inhibitor, which is in Phase II clinical for the treatment of non-small cell lung cancer (NCSLC); and in Phase Ib clinical trial to treat NCSLC patients with Casitas B-lineage Lymphoma genetic alterations, as well as KRAS G12C inhibitor program for NSCLC adenocarcinoma patients, colorectal cancer patients, and other cancers. It also develops mocetinostat, an orally investigational selective Class I and IV histone deacetylase inhibitor that has completed Phase II clinical trial in combination with durvalumab for the treatment of patients with NSCLC. The company has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

About Sunwin Stevia International

Sunwin Stevia International, Inc. produces and sells stevioside, a natural sweetener; and herbs used in traditional Chinese medicines and veterinary products primarily in the People's Republic of China. It operates through two segments, Stevioside and Chinese Medicines. The Stevioside segment produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. Its products include Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie, dietary supplement. This segment sells its products to food and drug manufacturers, and ingredient distributor foreign trade companies. The Chinese Medicines segment manufactures and sells traditional Chinese medicine formula extracts, which are used in products made for use by humans and animals. Its extracts consists of single traditional Chinese medicine extracts; compound traditional Chinese medicine extracts; and purified extracts, including active parts and monomer compounds, such as soy isoflavone. This segment offers traditional Chinese medicine formula extracts to traditional Chinese medicine manufacturers and animal pharmaceutical manufacturers. Sunwin Stevia International, Inc. is based in Qufu, China.

Receive News & Ratings for Mirati Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirati Therapeutics and related companies with's FREE daily email newsletter.